MACC1 regulates PDL1 expression and tumor immunity through the c‐Met/AKT/mTOR pathway in gastric cancer cells
Abstract Background Immunotherapy and its mechanisms are being studied in a wide variety of cancers. Programmed cell death ligand 1 (PDL1) is associated with immune evasion in numerous tumor types. Here, we aimed to assess the relationship between metastasis associated in colon cancer‐1 (MACC1) and...
Main Authors: | Gangling Tong, Boran Cheng, Jingzhang Li, Xuan Wu, Qiaohong Nong, Lirui He, Xi Li, Laiqing Li, Shubin Wang |
---|---|
Format: | Article |
Language: | English |
Published: |
Wiley
2019-11-01
|
Series: | Cancer Medicine |
Subjects: | |
Online Access: | https://doi.org/10.1002/cam4.2542 |
Similar Items
-
MACC1 and MET as markers associated with progression and metastasis in cutaneous melanoma
by: Yan Zhou, et al.
Published: (2023-07-01) -
Identification of <it>MACC1 </it>as a novel prognostic marker in hepatocellular carcinoma
by: Lu Canliang, et al.
Published: (2011-09-01) -
Prognostic Value of MACC1 and c-met Expressions in Non-small Cell Lung Cancer
by: Xingsheng HU, et al.
Published: (2012-07-01) -
MACC1 Contributes to the Development of Osteosarcoma Through Regulation of the HGF/c-Met Pathway and Microtubule Stability
by: Jia Wen, et al.
Published: (2020-12-01) -
MACC1 Suppresses Cell Apoptosis in Hepatocellular Carcinoma by Targeting the HGF/c-MET/AKT Pathway
by: Yingmin Yao, et al.
Published: (2015-02-01)